Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
Botulinum toxin serotype-A (BoNT-A) preparations are widely used to improve the appearance of wrinkles. While effective and well tolerated, patients require retreatment over time to re-establish the effects. There is growing interest from patients as to whether higher doses can prolong response with...
Main Authors: | Joely Kaufman-Janette, Sue Ellen Cox, Steven Dayan, John Joseph |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/7/494 |
Similar Items
-
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
by: Koenraad De Boulle, et al.
Published: (2010-04-01) -
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01) -
Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
by: Fraint A, et al.
Published: (2016-02-01) -
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
by: Kaku M, et al.
Published: (2016-03-01) -
AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
by: Malgorzata Field, et al.
Published: (2018-12-01)